Anúncio
Anúncio

MGRX

MGRX logo

Mangoceuticals, Inc. Common Stock

0.98
USD
Patrocinado
+0.10
+11.44%
08 de jan., 15:59 UTC -5
Encerrado
exchange

Pós-Mercado

0.93

-0.05
-5.21%

Relatórios de Lucros MGRX

Rácio de surpresa positiva

Nenhum Dado Disponível para MGRX

%

Próximo Relatório

Data do Próximo Relatório
20 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
--

Mangoceuticals, Inc. Common Stock earnings per share and revenue

On 14 de nov. de 2025, MGRX reported earnings of -0.69 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 80.00 mil, compared to an expected --, with a --% difference. The market reacted with a -14.86% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Mangoceuticals, Inc. Common Stock reported EPS of -$0.69, missing estimates by --, and revenue of $80.00K, -- -- expectations.
The stock price moved down -14.86%, changed from $1.48 before the earnings release to $1.26 the day after.
The next earning report is scheduled for 20 de mar. de 2026.
Based on -- analistas, Mangoceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio